Ad
BIO Short Information Bio-Rad Laboratories Inc. Class A
Short Information | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 17,261 |
| Total Actual Volume | 3,130,541 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 863 |
| Average Short Percentage | 0.59% |
Is there a BIO Short Squeeze or Breakout about to happen?
See the BIO Short Analysis for free Sign up or Login
Powered by Squeeze Report
BIO Twenty Trading Day's Volume to Short Volume Chart
BIO Twenty Trading Day Price Chart
BIO Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-22-2025 | $353.29 | $360.54 | $360.93 | $351.625 | 152,619 | 1,426 | 0.93% |
| 01-21-2025 | $344.51 | $353.86 | $354.73 | $342.955 | 144,397 | 2,843 | 1.97% |
| 01-17-2025 | $341.77 | $342.41 | $345.7579 | $341.38 | 124,273 | 89 | 0.07% |
| 01-16-2025 | $341.79 | $344.47 | $345.485 | $335.6 | 147,255 | 889 | 0.6% |
| 01-15-2025 | $344.63 | $341.79 | $350.82 | $334.57 | 247,178 | 2,180 | 0.88% |
| 01-14-2025 | $351.7 | $342.23 | $355.05 | $336.6704 | 206,292 | 2,353 | 1.14% |
| 01-13-2025 | $342.34 | $351.7 | $352.795 | $342.34 | 121,472 | 435 | 0.36% |
| 01-10-2025 | $335.63 | $341.75 | $344.37 | $335.42 | 132,666 | 990 | 0.75% |
| 01-08-2025 | $339.32 | $344.38 | $347.11 | $337.365 | 139,020 | 1,024 | 0.74% |
| 01-07-2025 | $344.48 | $343.99 | $351.96 | $340.72 | 116,725 | 1,022 | 0.88% |
| 01-06-2025 | $331.44 | $343.47 | $346.87 | $331.44 | 174,451 | 418 | 0.24% |
| 01-03-2025 | $326.78 | $330.75 | $335.0623 | $324.22 | 111,502 | 415 | 0.37% |
| 01-02-2025 | $330.19 | $326.16 | $335.79 | $324.56 | 108,632 | 720 | 0.66% |
| 12-31-2024 | $329.39 | $328.51 | $329.39 | $325.745 | 103,813 | 949 | 0.91% |
| 12-30-2024 | $328 | $326.34 | $328.74 | $323.05 | 101,317 | 117 | 0.12% |
| 12-27-2024 | $329.59 | $330.87 | $332.13 | $326.56 | 77,926 | 142 | 0.18% |
| 12-26-2024 | $328.35 | $331.39 | $332.34 | $328.35 | 86,181 | 225 | 0.26% |
| 12-24-2024 | $329.95 | $330.53 | $330.53 | $323.5625 | 40,545 | 7 | 0.02% |
| 12-23-2024 | $325.44 | $328.36 | $328.885 | $323.7 | 102,987 | 585 | 0.57% |
| 12-20-2024 | $325.72 | $327.47 | $334.0996 | $325.72 | 691,290 | 432 | 0.06% |
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Bio-Rad Laboratories Inc. Class A Website:
Ad
-
Bio-Rad leads investment to support the launch of ColoSense ® , a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease Geneoscopy, Inc. , a life sciences company focused on developing diagnostic tests for the adv...
-
2025-01-03 05:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz, Chief Operating Officer Jon DiVincenzo, and Chief Financial Officer Roop K. Lakkaraju will host...